Intellectual property policies in early-phase research in public-private partnerships

Nat Biotechnol. 2016 May 6;34(5):504-10. doi: 10.1038/nbt.3562.

Hilde Stevens^{1

2

3}, Geertrui Van Overwalle^{2

4}, Bart Van Looy^{5

6}, Isabelle Huys^{1

2}

¹ Department of Pharmaceutical and Pharmacological Sciences, Research Centre for Clinical Pharmacology and Pharmacotherapy, University of Leuven, Leuven, Belgium.
² Centre for IT &IP Law (CiTiP), University of Leuven, Leuven, Belgium.
³ Institute for Interdisciplinary Innovation in healthcare (Ih), Université libre de Bruxelles, Brussels, Belgium.
⁴ Visiting professor, Tilburg University, Tilburg, the Netherlands.
⁵ Department of Managerial Economics, Strategy and Innovation, University of Leuven, Leuven, Belgium.
⁶ Centre for Research and Development Monitoring, Leuven, Belgium.

No abstract available

MeSH terms